0001615774-17-003293.txt : 20170621 0001615774-17-003293.hdr.sgml : 20170621 20170621170041 ACCESSION NUMBER: 0001615774-17-003293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170620 FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MATHER CHARLES E IV CENTRAL INDEX KEY: 0001563422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36019 FILM NUMBER: 17923365 MAIL ADDRESS: STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP STREET 2: 509 MADISON AVE., SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 4 1 s106635_form4.xml OWNERSHIP DOCUMENT - CHARLES E. MATHER IV X0306 4 2017-06-20 0 0001430306 Tonix Pharmaceuticals Holding Corp. TNXP 0001563422 MATHER CHARLES E IV C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022 1 0 0 0 Stock Option 4.18 2017-06-20 4 A 0 20000 0.00 A 2018-06-20 2027-06-20 Common Stock 20000 20000 D The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan. /s/Jessica Morris, Attorney-in-Fact 2017-06-21